Navigation Links
Neuromonics Unveils New Device to Relieve Mild, Moderate Tinnitus at Audiology NOW!
Date:3/28/2013

Bethlehem, PA (PRWEB) March 28, 2013

Neuromonics, Inc., is introducing the first device specifically designed to help individuals suffering from mild to moderate tinnitus.

The Neuromonics Sanctuary™ device is the company’s newest product to help tinnitus patients. The company will debut the Sanctuary at the Audiology NOW! Conference April 3-6 in Anaheim, Calif., at Booth No. 1660. Neuromonics also will showcase its Oasis, the FDA-cleared, patented and clinically proven device that offers long-term, significant relief for serious tinnitus sufferers. “With the addition of the Sanctuary, Neuromonics can provide effective, simple treatment for the full range of those dealing with tinnitus,” says Curtis Amann, vice president of marketing and sales for the company.

Tinnitus is often described as buzzing, ringing, hissing, humming, roaring, or whistling that someone hears in the absence of any external sound. More than 50 million people in the United States alone suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, the problem is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from tinnitus.

The Neuromonics Sanctuary provides relief of tinnitus symptoms by combining relaxing music with a customized neural stimulus. The Sanctuary blends a customized, high-frequency signal with music, providing an on-demand sense of control and relief to the individual. Patients with mild or moderate tinnitus disturbance can experience relief within minutes of their tinnitus assessment, according to Amann.

Ease of use
The compact Sanctuary device is simple to use, functioning much like familiar consumer music players, and fits easily into patients’ lifestyles, says Amann. Tinnitus sufferers can choose from one of three pre-programmed profiles to find the signal that provides the greatest degree of relief from their particular symptoms. Pressing “play” allows them to listen to calming, relaxing music that interacts with the tinnitus perception.

Individuals use the Sanctuary at times when their tinnitus is bothersome, says Amann. “The Sanctuary provides relief while listening to the device -- when you want it and when you need it.”

Tinnitus sufferers can begin to determine if the Sanctuary is the right choice for them by taking Neuromonics’ online tinnitus assessment. A trained audiology clinician will review the score during an assessment visit and determine if the Sanctuary is the appropriate device. The Neuromonics Sanctuary is a Class II medical device, regulated by the FDA and requiring a prescription from a trained clinician.

Key features
The Sanctuary is not a masking device, but rather works to promote new neural connections that will allow the brain to help filter out the tinnitus perception. Key features of the simple device include the following.

  •     Simple setup and same-day fitting
  •     User-friendly interface
  •     Sleep timer
  •     Multiple headphone options
  •     Bedside speaker accesory

Long-term tinnitus relief
The Neuromonics Sanctuary device works with the same principles as the Neuromonics Oasis, the gold standard for long-term reduction of tinnitus disturbance and awareness. The Sanctuary is designed for situational relief. In contrast, the FDA-cleared, patented and clinically proven Neuromonics Oasis, in combination with the Neuromonics Tinnitus Treatment, is a long-term treatment program for those with more severe tinnitus.

Neuromonics, Inc. (http://www.neuromonics.com)
Based in Bethlehem, Pa., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The Sanctuary provides situational relief for those suffering from mild to moderate tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term significant relief for those with severe tinnitus. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. The treatment has been featured on national news media including The Doctors and CNN.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10574661.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. IQware Solutions Unveils New Website, New Corporate Identity
2. CustomerCentric Selling® Unveils New Client Testimonial Videos to Showcase Significant Sales Success
3. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
4. 'EMT Exam Ace' Unveils Free Sample EMT Practice Quizzes
5. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
6. Naturel Collagen Canada Unveils C RUM, the Newest Addition to the Revolutionary Natural Collagen Skin Care Product Line
7. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
8. Garden Media Unveils 2013-14 Garden Trends: ‘Finding Bliss in the Garden’- Part 3
9. Garden Media Group Unveils New Marketing and Public Relations Blog, GROW
10. Physicians Indemnity Risk Retention Group Unveils New Website
11. Marketing Xocolate International Corporation (MXI Corp) Unveils New Healthy Dark Chocolate Product: Xoçai™ Nuggets, Which Are Both Diabetic And Vegan Friendly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: